Exploring the utility of TP53 mutations as prognostic markers in patients with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Wang, Y. [1 ]
Zuo, J. [1 ]
Feng, L. [1 ]
Fan, Z. [1 ]
Wang, L. [1 ]
Zhang, X. [1 ]
Han, J. [1 ]
Zhou, X. [1 ]
Ye, J. [2 ]
Li, B. [2 ]
Lizaso, A. [2 ]
Zhou, J. [2 ]
机构：
[1] Hebei Med Univ, Hosp 4, Med Oncol, Shijiazhuang, Hebei, Peoples R China
[2] Burning Rock Biotech, Med, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1431
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1229P
引用
收藏
页码：S799 / S800
页数：2
相关论文
共 50 条
  • [21] Association of TP53 mutation status with clinical outcomes in patients with EGFR mutated non-small cell lung cancer (NSCLC)
    Ahmed, Saman
    Aggarwal, Charu
    Mick, Rosemarie
    Bauml, Joshua
    Cohen, Roger
    Kadauke, Stephan
    Sterlicchi, Trisha
    Evans, Tracey L.
    Kucharczuk, John C.
    Desphande, Charu
    Morrissette, Jennifer J. D.
    Daber, Robert
    Langer, Corey J.
    CANCER RESEARCH, 2015, 75
  • [22] Prognostic impact of TP53 mutations in metastatic non-squamous non-small-cell lung cancer
    Mathiot, Laurent
    Nigen, Benoit
    Goronflot, Thomas
    Hiret, Sandrine
    Doucet, Ludovic
    Pons-Tostivint, Elvire
    Bennouna, Jaafar
    Denis, Marc G.
    Herbreteau, Guillaume
    Raimbourg, Judith
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Nondisruptive mutations of TP53 and overall survival (OS) in advanced non-small-cell lung cancer (NSCLC) patients (p)
    Costa, Enric Carcereny
    Bertran-Alamillo, Jordi
    Molina-Vila, Miguel Angel
    Gervais, Radj
    Massuti, Bartomeu
    Bonanno, Laura
    Moran, Teresa
    Majem, Margarita
    Felip, Enriqueta
    Garcia-Campelo, M. Rosario
    Vergnenegre, Alain
    Ramirez, Santiago Viteri
    Gasco, Amaya
    Wannesson, Luciano
    Mayo-de las Casas, Clara
    Pujantell-Pastor, Laia
    Favaretto, Adolfo G.
    Karachaliou, Niki
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Prognostic effect of coexisting TP53 and ZFHX3 mutations in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Zhang, Lijuan
    Zhang, Tongyan
    Shang, Bin
    Li, Yaqiong
    Cao, Zhixin
    Wang, Hui
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 94 (03)
  • [25] Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer
    Cho, Sukki
    Kim, Min Jung
    Choi, Yi Young
    Yoo, Seung Soo
    Lee, Won Kee
    Lee, Eun Jin
    Jang, Eun Jeong
    Bae, Eun Young
    Jin, Guang
    Jeon, Hyo-Sung
    Lee, Shin Yup
    Cha, Sung-Ick
    Park, Tae In
    Kim, Chang Ho
    Park, Jae Yong
    LUNG CANCER, 2011, 73 (01) : 25 - 31
  • [26] TP53 somatic mutations are associated with poor survival in non-small cell lung cancer patients who undergo immunotherapy
    Zhao, Liqin
    Qu, Xiaofei
    Wu, Zhenhua
    Li, Yuehua
    Zhang, Xiaowei
    Guo, WeiJian
    AGING-US, 2020, 12 (14): : 14556 - 14568
  • [27] Impact of TP53 mutations on brain metastasis control in non-small cell lung cancer patients undergoing stereotactic radiosurgery
    Leng, Jim X.
    Su, Chang
    Carpenter, David J.
    Floyd, Warren
    Vaios, Eugene
    Shenker, Rachel
    Hendrickson, Peter G.
    Giles, Will
    Mullikin, Trey
    Floyd, Scott R.
    Kirkpatrick, John P.
    Green, Michelle
    Reitman, Zachary J.
    JOURNAL OF RADIOSURGERY AND SBRT, 2024, 9 (02):
  • [28] Prognostic value of KRAS/TP53/PIK3CA in non-small cell lung cancer
    Zhao, Jiayi
    Han, Yiping
    Li, Jiamei
    Chai, Rong
    Bai, Chong
    ONCOLOGY LETTERS, 2019, 17 (03) : 3233 - 3240
  • [29] Clinico-Molecular Characteristics and Prognostic Outcomes of TP53 Mutated Patients with Advanced Non-Small Cell Lung Cancer
    Song, Z.
    Hu, L.
    Han, Q.
    Wang, X.
    Huo, Y.
    Jiao, T.
    Ren, G.
    Wang, K.
    Yin, B.
    Jia, Y.
    Song, J.
    Cheng, H.
    Wang, H.
    Lou, F.
    Cao, S.
    Zang, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S656 - S656
  • [30] The Influence of TP53 Mutations on the Prognosis of Patients With Early Stage Non-Small Cell Lung Cancer May Depend on the Intratumor Heterogeneity of the Mutations
    Lee, Shin Yup
    Jeon, Hyo-Sung
    Hwangbo, Yup
    Jeong, Ji Yun
    Park, Ji Young
    Lee, Eun Jin
    Jin, Guang
    Shin, Kyung Min
    Yoo, Seung Soo
    Lee, Jaehee
    Lee, Eung Bae
    Cha, Seung Ick
    Kim, Chang Ho
    Park, Jae Yong
    MOLECULAR CARCINOGENESIS, 2015, 54 (02) : 93 - 101
12345